Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0B27
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,770
Award facts
- Contract value 100% obligated
- $1,770.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,770.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on October 21, 2025, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) within the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order represents a firm fixed-price purchase of pharmaceutical products and medical consumables required to support the Department of Defense's healthcare operations. No set-aside designation was applied to this award, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group's IDC under PPV-G GEN V carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning the company as a critical regional pharmaceutical supplier for military healthcare facilities worldwide. The broader PPV-G GEN V acquisition strategy represents a $30.3 billion strategic initiative designed to streamline pharmaceutical supply chain operations across the DoD. DMS Pharmaceutical Group's product portfolio includes branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables, enabling the company to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system. As the prime contractor on this delivery order, DMS Pharmaceutical Group carries full performance responsibility with no identified subcontractors.
Quick answers
Who was awarded contract SPE2DU26F0B27?
SPE2DU26F0B27 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DU26F0B27 worth?
The government has obligated $1,770 on SPE2DU26F0B27.
Is contract SPE2DU26F0B27 an order under another contract?
Yes. SPE2DU26F0B27 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0B27 competed?
The extent of competition for SPE2DU26F0B27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award